Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine

Figure 9

RMSD matrix and clustering diagram of MD conformations from 15 to 20 ns. (a) Tetrahydropalmatine, (b) Reserpiline, (c) (+)-Corydaline, and (d) Dinaciclib.

(a)

(b)

(c)

(d)